KTTA — Pasithea Therapeutics Corp

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $0.37 Analyst target: $3.00 Upside: 710.37%

About Pasithea Therapeutics Corp

Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida.

See the full interactive analysis & chart →

Informational only — not investment advice.